Indolizine derivatives hold essential biological functions and have been researched for hypoglycemic, antibacterial, anti-inflammatory, analgesic, and anti-tumor actions. Indolizine scaffold has intrigued conjecture and continuous attention and has become an effective parent system for generating powerful novel medication candidates. This research focused on applying the quantitative structure-electrochemistry relationship (QSER) approach to the half-wave potential (E1/2) for Indolizine derivatives using theoretical molecular descriptors. After calculating the descriptors and splitting the data into both sets, training and prediction. The QSER model was constructed using the Genetic Algorithm/Multiple Linear Regression (GA/MLR) technique, which was used to choose the optimal descriptors for the model. A four-parameter model has been established. Many assessment procedures, including cross-validation, external validation, and Y-scrambling testing, were used to assess the model's performance. Furthermore, the applicability domain (AD) was investigated using the Williams and Insubria graphs to assess the correctness of the established model's predictions. The constructed model exhibits great goodness-of-fit to experimental data, as well as high stability (R²=0.893, Q²LOO= 0.851, Q²LMO=0.843 RMSEtr= 0.052, s= 0.056). Prediction results show a good agreement with the experimental data of E1/2 (R²ext= 0.912, Q²F1= 0.883, Q²F2= 0.883, Q²F3= 0.919, CCCext= 0.942, RMSEext=0.045).
A two-level full factorial design with interactions effectively used to screen for parameters impacting the degradation of Direct Red 89 (DR 89) by thermally activated persulfate. Four variables were identified as critical: reaction temperature (T), persulfate concentration ([PS]), initial pH of medium (pH) and initial DR 89 concentration ([DR89]i). The fit goodness of the reduced model tested by performing plots of descriptive statistic, residuals versus predicted responses, normal probability versus residuals and observed versus predicted values, as well as examining the ANOVA table. The observed and the predicted response values of the reduced model exhibited a good correlation, with R2, R2adj, Q2 and ‘p’ of 0.990, 0.983, 0.968 and 0.000, respectively. To determine optimal operating parameters, the desirability function utilized, and it determined to be 0.988 with a predicted response of 99.89% for an initial DR 89 concentration of 51.96 mg/L, a persulfate concentration of 12 mM, a reaction temperature of 60 °C and a pH of 3.
In this work, the liquid chromatography retention time in monomeric and polymeric stationary phases of PAHs was investigated. Quantitative structure retention relationship approach has been successfully performed. At first, 3224 molecular descriptors were calculated for the optimized PAHs structure using Dragon software. Afterwards, the modelled dataset was divided using the CADEX algorithm into two subsets for internal and external validation. The genetic algorithm-based on a multiple linear regression was used for feature selection of the most significant descriptors and the model development. The selected models included five descriptors: nCIR, GGI3, GGI4, JGT, and DP14 were used for the monomeric column and nR10, EEig01x, L1m, H5v, HATS6v were introduced for the polymeric column. Robustness and predictive performance of the suggested models were verified by both internal and external statistical validation. The good quality of the statistical parameters indicates the stability and predictive power of the suggested models. This study demonstrated that the suitability of the established models in the prediction of liquid chromatographic retention indices of PAHs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.